Home Βιογραφικό Σημείωμα Ε. Λαμπρινουδάκη

Who's Online

Έχουμε 143 επισκέπτες συνδεδεμένους
Διαφήμιση
Βιογραφικό Ε. Λαμπρινουδάκη PDF Εκτύπωση E-mail

 Lamprinoudaki 

ΕΙΡΗΝΗ ΛΑΜΠΡΙΝΟΥΔΑΚΗ

Ιατρός Ενδοκρινολόγος

Αναπληρώτρια Καθηγήτρια

Β΄ Μαιευτικής και Γυναικολογικής Κλινικής

Πανεπιστημίου Αθηνών

Αρεταίειο Νοσοκομείο,

Β. Σοφίας 76, Αθήνα 11528

Τηλέφωνο: 210-7286284

FAX: 210-7233330

e-mail: ilambrinoudaki@aretaieio.uoa.gr

 

(τελευταία ενημέρωση 15 Ιανουαρίου 2013)

 


 

 

 

 
  1. ΕΚΠΑΙΔΕΥΣΗ ΚΑΙ ΚΛΙΝΙΚΗ ΔΡΑΣΤΗΡΙΟΤΗΤΑ:

1973-1985: Πρωτοβάθμια και Δευτεροβάθμια εκπαίδευση στο Αρσάκειο Σχολείο Ψυχικού.

1985-1991:  Φοιτήτρια Ιατρικής Σχολής Πανεπιστημίου Αθηνών μετά από επιτυχείς Πανελλαδικές εξετάσεις.

30.7.1991:     Πτυχίο Ιατρικής Σχολής Αθηνών με το βαθμό «Άριστα».

1991-1992: Υποχρεωτική Υπηρεσία Υπαίθρου στο Κέντρο Υγείας Χαλκιοπούλων Αιτωλοακαρνανίας.

10.1992 - 12.1995: Εκπόνηση Διδακτορικής Διατριβής στην 1η Παθολογική Κλινική της Ιατρικής Σχολής του Πανεπιστημίου της Χαϊδελβέργης, Γερμανίας με θέμα. “Συσχέτιση των ενδογενών στεροειδών του φύλου με την οστική πυκνότητα υγιών ανδρών και γυναικών άνω των 50 ετών: πληθυσμιακή μελέτη.»

2.1994 - 2.2000:   Ειδίκευση στην Ενδοκρινολογία στα εξής Τμήματα: 1) Τμήμα Ενδοκρινολογίας και Μεταβολισμού, 1η Παθολογική Κλινική της Ιατρικής Σχολής του Πανεπιστημίου της Χαϊδελβέργης, Γερμανίας 2) Κλινική Παθολογικής Φυσιολογίας Πανεπιστημίου Αθηνών, Λαϊκό Νοσοκομείο, 3) Τμήμα Ενδοκρινολογίας και Μεταβολισμού, Γενικό Κρατικό Νοσοκομείο Νίκαιας Πειραιώς και 4) Τμήμα Ενδοκρινολογίας και Μεταβολισμού Πανεπιστημίου Hong Kong, Noσοκομείο Queen Mary, Hong Kong, Κίνα.

5. 2000: Άδεια Άσκησης της Ειδικότητας της Ενδοκρινολογίας μετά από επιτυχείς εξετάσεις (Αρ. Αδείας: 3915/19.5.2000).

9.2000 – 5.2003: Επιστημονική Συνεργάτις στην Β’ Μαιευτική και Γυναικολογική Κλινική του Πανεπιστημίου Αθηνών, στο Αρεταίειο Νοσοκομείο.

5.2003 – 7.2008: Λέκτορας στην Β’ Μαιευτική και Γυναικολογική Κλινική του Πανεπιστημίου Αθηνών, στο Αρεταίειο Νοσοκομείο.

Από 7.2008: Επίκουρη Καθηγήτρια στην Β’ Μαιευτική και Γυναικολογική Κλινική του Πανεπιστημίου Αθηνών, στο Αρεταίειο Νοσοκομείο.

Από 11.2012: Αναπληρώτρια Καθηγήτρια στην Β’ Μαιευτική και Γυναικολογική Κλινική του Πανεπιστημίου Αθηνών, στο Αρεταίειο Νοσοκομείο.

Υπεύθυνη του Ιατρείου Εμμηνόπαυσης της Β’ Μαιευτικής και Γυναικολογικής Κλινικής, το οποίο εξυπηρετεί περίπου 1500 γυναίκες ετησίως από την Αθήνα και την κεντρική και νότια Ελλάδα.

.

  1.  ΔΙΔΑΚΤΙΚΟ ΕΡΓΟ

Μαθήματα προπτυχιακών φοιτητών Ιατρικής Σχολής Αθηνών:

-       Κλιμακτήριος και Εμμηνόπαυση (11ο-12ο εξάμηνο),

-       Μετεμμηνοπαυσιακή οστεοπόρωση (11ο-12ο εξάμηνο).

-       Εισαγωγή στην Κλινική Ενδοκρινολογία: διαταραχές ασβεστίου και βιταμίνης D

-       Κλινική Ενδοκρινολογία: Μετεμμηνοπαυσιακή Ορμονική Θεραπεία

-       Φυσιολογία του Οστίτη Ιστού: θεραπευτικά σχήματα οστεοπόρωσης

-       Διαταραχές των ορμονών του φύλου στους βαρέως πάσχοντες

-       Διερεύνηση και αντιμετώπιση της πρωτοπαθούς αμηνόρροιας στην εφηβεία

Μαθήματα μεταπτυχιακών φοιτητών Ιατρικής Σχολής:

- Εμμηνόπαυση και ορμονική θεραπεία

- Εμμηνόπαυση και SERMS

- Διάγνωση και θεραπεία οστεοπόρωσης

Διδακτορικές διατριβές

-          Από το 2003 μετέχω στις 3μελείς επιτροπές 40 διδακτορικών διατριβών, εκ των οποίων 13 έχουν περατωθεί.

 

3. ΕΡΕΥΝΗΤΙΚΟ KAI ΑΚΑΔΗΜΑΪΚΟ ΕΡΓΟ

- 105 ξενόγλωσσες δημοσιεύσεις σε διεθνή περιοδικά (ηλεκτρονική βάση δεδομένων PubMed).

- 22 δημοσιεύσεις σε ελληνικά περιοδικά

- 10 κεφάλαια σε ιατρικά βιβλία.

- 113 ανακοινώσεις σε διεθνή συνέδρια

- 96 ανακοινώσεις σε ελληνικά συνέδρια

- 80 διαλέξεις μετά από πρόσκληση σε ελληνικά και διεθνή συνέδρια .

- Μέλος της Συντακτικής Επιτροπής του περιοδικού MATURITAS

- Διοργάνωση και διδασκαλία «σχολείων εμμηνόπαυσης» το 2010 στην Κωνσταντινούπολη, το 2011 στην Φλωρεντία και το 2012 στο Δουβλίνο, υπό την αιγίδα της European Menopause and Andropause Society.

- Οργάνωση των Πανελληνίων Συνεδρίων Εμμηνόπαυσης, τα οποία πραγματοποιούνται κάθε 3 χρόνια, και του Πανευρωπαϊκού Συνεδρίου Εμμηνόπαυσης 2012 στην Αθήνα.

- Συγγραφή και παρουσίαση των Ελληνικών κατευθυντήριων οδηγιών για τη χρήση της ορμονικής θεραπείας στην εμμηνόπαυση. Παρουσίαση στην Αθήνα τον Ιούνιο 2012 και στη Θεσσαλονίκη τον Φεβρουάριο 2013.

 

4. ΕΠΙΣΤΗΜΟΝΙΚΕΣ ΕΤΑΙΡΕΙΕΣ

Αντιπρόεδρος της European Menopause and Andropause Society

Γενική Γραμματέας της Ελληνικής Εταιρείας Κλιμακτηρίου και Εμμηνόπαυσης

Μέλος της International Menopause Society

Μέλος της Ελληνικής Ενδοκρινολογικής Εταιρείας

Μέλος της Ελληνικής Εταιρείας Γυναικολογικής Ενδοκρινολογίας

Μέλος της Ελληνικής Εταιρείας Μεταβολισμού των Οστών

 

5. ΓΛΩΣΣΕΣ

- Αγγλικά (Proficiency, Cambridge)

- Γερμανικά (Grosses Deutsches Sprachdiplom)

 

6. ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΠΕΡΙΟΔΙΚΑ

EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women.

Pérez-López FR, Ceasu I, Depypere H, Erel CT, Lambrinoudaki I, Rees M, Schenck-Gustafsson K, Tremollieres F, van der Schouw YT, Simoncini T. Maturitas. 2013 Jan 3. doi:pii: S0378-5122(12)00406-9. 10.1016/j.maturitas.2012.12.006. [Epub ahead of print]

 

Hormone therapy and the prevention of cardiovascular disease and cognitive decline: Where do we stand?

Lambrinoudaki I, Pérez-López FR. Maturitas. 2013 Feb;74(2):107-8. doi: 10.1016/j.maturitas.2012.11.008. Epub 2012 Dec 21. No abstract available.

 

Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.

Lambrinoudaki I, Patikas E, Kaparos G, Armeni E, Rizos D, Thoda P, Alexandrou A, Antoniou A, Tsivgoulis G, Gatzonis S, Panoulis C, Triantafyllou N. Neurol Sci. 2012 Dec 5. [Epub ahead of print]

 

EMAS position statement: Diet and health in midlife and beyond. 

Lambrinoudaki I, Ceasu I, Depypere H, Erel T, Rees M, Schenck-Gustafsson K, Simoncini T, Tremollieres F, van der Schouw YT, Pérez-López FR. Maturitas. 2013 Jan;74(1):99-104. doi: 10.1016/j.maturitas.2012.10.019. Epub 2012 Nov 28.

 

MTHFR C677T polymorphism modifies the effect of HRT on metabolic parameters in postmenopausal women. 

Lambrinoudaki I, Papadimitriou D, Kaparos G, Rizos D, Panoulis C, Deligeoroglou E, Alexandrou A, Auguolea A, Apostolakis M, Creatsa M, Kouskouni E. Climacteric. 2012 Nov 12. [Epub ahead of print]

 

Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors. 

Grigoriou V, Augoulea A, Armeni E, Rizos D, Alexandrou A, Dendrinos S, Panoulis K, Lambrinoudaki I. Gynecol Endocrinol. 2013 Feb;29(2):125-8. doi: 10.3109/09513590.2012.708801. Epub 2012 Jul 31.

 

Can premenstrual syndrome affect arterial stiffness or blood pressure? 

Stamatelopoulos KS, Georgiopoulos G, Papaioannou T, Lambrinoudaki I, Kouzoupis A, Vlachopoulos C, Georgiou SP, Manios E, Alevizaki M, Papamichael CM, Sfikakis PP. Atherosclerosis. 2012 Sep;224(1):170-6. doi: 10.1016/j.atherosclerosis.2012.05.037. Epub 2012 Jul 20.

 

EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy.

Rees M, Pérez-López FR, Ceasu I, Depypere H, Erel T, Lambrinoudaki I, Schenck-Gustafsson K, Simoncini T, van der Schouw Y, Tremollieres F. Maturitas. 2012 Oct;73(2):171-4. doi: 10.1016/j.maturitas.2012.06.009. Epub 2012 Jul 20.

 

Effect of tibolone and raloxifene on serum markers of apoptosis in postmenopausal women.

Lambrinoudaki I, Karaflou M, Kaparos G, Alexandrou A, Creatsa M, Aravantinos L, Augoulea A, Kouskouni E. Climacteric. 2012 May 29. [Epub ahead of print]

 

Recommendations on the management of fragility fracture risk in women younger than 70 years.

Palacios S, Christiansen C, Sánchez Borrego R, Gambacciani M, Hadji P, Karsdal M, Lambrinoudaki I, Lello S, O'Beirne B, Romao F, Rozenberg S, Stevenson JC, Ben-Rafael Z. Gynecol Endocrinol. 2012 Oct;28(10):770-86. doi: 10.3109/09513590.2012.679062. Epub 2012 May 7.

 

Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress.

Augoulea A, Alexandrou A, Creatsa M, Vrachnis N, Lambrinoudaki I. Arch Gynecol Obstet. 2012 Jul;286(1):99-103. doi: 10.1007/s00404-012-2357-8. Epub 2012 May 1. Review.

 

Previous gestational diabetes mellitus and markers of cardiovascular risk.

Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G.

Int J Endocrinol. 2012;2012:458610. doi: 10.1155/2012/458610. Epub 2012 Mar 18.

 

Serum lipid levels and bone mineral density in Greek postmenopausal women.

Pliatsika P, Antoniou A, Alexandrou A, Panoulis C, Kouskouni E, Augoulea A, Dendrinos S, Aravantinos L, Creatsa M, Lambrinoudaki I. Gynecol Endocrinol. 2012 Aug;28(8):655-60. doi: 10.3109/09513590.2011.650766. Epub 2012 Feb 10.

 

High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women.

Lambrinoudaki I, Armeni E, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Deligeoroglou E, Livada A, Psychas C, Creatsa M, Bouboulis G, Alevizaki M, Stamatelopoulos K. J Hypertens. 2012 Mar;30(3):592-9. doi: 10.1097/HJH.0b013e32834f5076.

 

Recently postmenopausal women have the same prevalence of subclinical carotid atherosclerosis as age and traditional risk factor matched men.

Stamatelopoulos KS, Armeni E, Georgiopoulos G, Kazani M, Kyrkou K, Stellos K, Koliviras A, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I. Atherosclerosis. 2012 Apr;221(2):508-13. doi: 10.1016/j.atherosclerosis.2011.12.006. Epub 2011 Dec 9.

 

Determinants of quality of life in Greek middle-age women: a population survey.

Giannouli P, Zervas I, Armeni E, Koundi K, Spyropoulou A, Alexandrou A, Kazani A, Areti A, Creatsa M, Lambrinoudaki I. Maturitas. 2012 Feb;71(2):154-61. doi: 10.1016/j.maturitas.2011.11.013. Epub 2011 Dec 16.

 

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.

Palacios S, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S. Maturitas. 2012 Feb;71(2):194-8. doi: 10.1016/j.maturitas.2011.11.010. Epub 2011 Dec 15. Review.

 

Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women.

Lambrinoudaki I, Augoulea A, Armeni E, Rizos D, Alexandrou A, Creatsa M, Kazani M, Georgiopoulos G, Livada A, Exarchakou A, Stamatelopoulos K. Climacteric. 2012 Aug;15(4):350-7. doi: 10.3109/13697137.2011.618564. Epub 2011 Dec 1.

 

EMAS position statement: Vitamin D and postmenopausal health.

Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Vujovic S, Rozenberg S, Rees M. Maturitas. 2012 Jan;71(1):83-8. doi: 10.1016/j.maturitas.2011.11.002. Epub 2011 Nov 17.

 

Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?

Sioulas VD, Politi E, Rizos D, Augoulea A, Kyroudi A, Sergentanis TN, Panoulis C, Aravantinos L, Creatsa M, Lambrinoudaki I. Climacteric. 2012 Apr;15(2):181-5. doi: 10.3109/13697137.2011.604144. Epub 2011 Nov 8.

 

Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.

Triantafyllou N, Lambrinoudaki I, Thoda P, Andreadou E, Kararizou E, Alexandrou A, Limouris G, Antoniou A, Tsivgoulis G. J Neurol Sci. 2012 Feb 15;313(1-2):137-41. doi: 10.1016/j.jns.2011.09.002. Epub 2011 Oct 10.

 

Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women.

Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C, Lambrinoudaki I. Metabolism. 2012 Feb;61(2):193-201. doi: 10.1016/j.metabol.2011.06.005. Epub 2011 Aug 4.

 

Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk.

Lambrinoudaki I, Armeni E, Georgiopoulos G, Kazani M, Kouskouni E, Creatsa M, Alexandrou A, Fotiou S, Papamichael C, Stamatelopoulos K. Int J Cardiol. 2011 Jul 5. [Epub ahead of print]

 

The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.

Creatsa M, Pliatsika P, Kaparos G, Antoniou A, Armeni E, Tsakonas E, Panoulis C, Alexandrou A, Dimitraki E, Christodoulakos G, Lambrinoudaki I. J Obstet Gynaecol Res. 2011 Oct;37(10):1415-22.

 

EMAS position statement: Managing menopausal women with a personal or family history of VTE.

Tremollieres F, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Vujovic S, Rozenberg S, Rees M. Maturitas. 2011 Jun;69(2):195-8. Epub 2011 Apr 12.

 

Sp1 collagen I A1 polymorphism in women with stress urinary incontinence.

Sioutis D, Economou E, Lambrinoudaki I, Tsamadias V, Creatsa M, Liapis A. Int Urogynecol J. 2011 Jul;22(7):835-9. Epub 2011 Feb 19.

 

EMAS position statement: Managing the menopause in the context of coronary heart disease.

Schenck-Gustafsson K, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Tremollieres F, Vujovic S, Rozenberg S, Rees M; EMAS. Maturitas. 2011 Jan;68(1):94-7. Epub 2010 Dec 14. Erratum in: Maturitas. 2011 Jun;69(2):e6.

 

EMAS position statement: Bone densitometry screening for osteoporosis.

Brincat M, Calleja-Agius J, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S; EMAS. Maturitas. 2011 Jan;68(1):98-101. Epub 2010 Nov 19. Erratum in: Maturitas. 2011 Jun;69(2):e5.

 

Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women.

Vitoratos N, Lambrinoudaki I, Rizos D, Armeni E, Alexandrou A, Creatsas G. Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):141-5. Epub 2010 Nov 11.

 

The frequency of early, spontaneous miscarriage associated with the leu33pro polymorphism of Glycoprotein IIIa: a pilot study.

Lambrinoudaki I, Armeni E, Kaparos GJ, Christodoulakos GE, Sergentanis TN, Alexandrou A, Creatsa M, Kouskouni E. Aust N Z J Obstet Gynaecol. 2010 Oct;50(5):485-90. doi: 10.1111/j.1479-828X.2010.01196.x.

 

Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI.

Lambrinoudaki I, Armeni E, Rizos D, Deligeoroglou E, Kofinakos P, Kaparos G, Alexandrou A, Creatsa M, Logothetis E, Kouskouni E. Obesity (Silver Spring). 2011 May;19(5):988-93. Epub 2010 Oct 14.

 

Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.

Lambrinoudaki I. Maturitas. 2011 Jan;68(1):13-6. Epub 2010 Oct 12. Review.

 

Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Lambrinoudaki I, Vlachou SA, Creatsas G. Curr Diabetes Rev. 2010 Nov;6(6):393-9. Review.

 

Pathophysiology of bone loss in the female athlete.

Lambrinoudaki I, Papadimitriou D. Ann N Y Acad Sci. 2010 Sep;1205:45-50. doi: 10.1111/j.1749-6632.2010.05681.x. Review.

 

Reproductive hormones and postpartum mood disturbances in Greek women.

Chatzicharalampous C, Rizos D, Pliatsika P, Leonardou A, Hasiakos D, Zervas I, Alexandrou A, Creatsa M, Konidaris S, Lambrinoudaki I. Gynecol Endocrinol. 2011 Aug;27(8):543-50. Epub 2010 Jul 23.

 

Androgens associated with advanced glycation end-products in postmenopausal women.

Diamanti-Kandarakis E, Lambrinoudaki I, Economou F, Christou M, Piperi C, Papavassiliou AG, Creatsas G. Menopause. 2010 Nov-Dec;17(6):1182-7.

 

EMAS position statement: Managing the menopause in women with a past history of endometriosis.

Moen MH, Rees M, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rozenberg S; European Menopause and Andropause Society. Maturitas. 2010 Sep;67(1):94-7.

 

EMAS position statement: Managing women with premature ovarian failure.

Vujovic S, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Rozenberg S, Rees M; European Menopause and Andropause Society. Maturitas. 2010 Sep;67(1):91-3. Epub 2010 Jun 3. Erratum in: Maturitas. 2011 Jun;69(2):e4.

 

BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.

Lambrinoudaki I, Kaparos G, Armeni E, Alexandrou A, Damaskos C, Logothetis E, Creatsa M, Antoniou A, Kouskouni E, Triantafyllou N. Eur J Neurol. 2011 Jan;18(1):93-8. doi: 10.1111/j.1468-1331.2010.03103.x.

 

Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.

Karaflou M, Kaparos G, Rizos D, Creatsa M, Christodoulakos G, Lambrinoudaki I. Fertil Steril. 2010 Nov;94(6):2399-401. Epub 2010 May 20.

 

The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Lambrinoudaki I, Karaflou M, Kaparos G, Grigoriou O, Alexandrou A, Panoulis C, Logothetis E, Creatsa M, Christodoulakos G, Kouskouni E. J Endocrinol Invest. 2010 Nov;33(10):720-4. Epub 2010 Apr 30.

 

EMAS position statement: managing obese postmenopausal women.

Lambrinoudaki I, Brincat M, Erel CT, Gambacciani M, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S.

Maturitas. 2010 Jul;66(3):323-6.

 

EMAS position statement: managing the menopause in women with epilepsy.

Erel CT, Brincat M, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rozenberg S, Rees M.

Maturitas. 2010 Jul;66(3):327-8. Epub 2010 Apr 24.

 

Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.

Triantafyllou N, Lambrinoudaki I, Armeni E, Evangelopoulos EM, Boufidou F, Antoniou A, Tsivgoulis G. J Neurol Sci. 2010 Mar 15;290(1-2):131-4. Epub 2010 Jan

 

Arterial wave reflections during the menstrual cycle of healthy women: a reproducibility study.

Papaioannou TG, Stamatelopoulos KS, Georgiopoulos G, Vlachopoulos C, Georgiou S, Lykka M, Lambrinoudaki I, Papamichael CM, Stefanadis CI.

Hypertension. 2009 Nov;54(5):1021-7. Epub 2009 Sep 8.

 

Endometriosis and other benign and malignant müllerian lesions in pelvic and extrapelvic organs.

Lambrinoudaki I, Augoulea A, Creatsa M, Vlachos N, Christodoulakos G, Papadias C. Anal Quant Cytol Histol. 2009 Jun;31(3):170-6.

 

Thyroid function and postpartum mood disturbances in Greek women.

Lambrinoudaki I, Rizos D, Armeni E, Pliatsika P, Leonardou A, Sygelou A, Argeitis J, Spentzou G, Hasiakos D, Zervas I, Papadias C. J Affect Disord. 2010 Mar;121(3):278-82. Epub 2009 Jul 25.

 

Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors.

Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, Lykka M, Kyrkou K, Rizos D, Creatsa M, Christodoulakos G, Alevizaki M, Sfikakis PP, Papamichael C.

Hypertension. 2009 Jul;54(1):98-105. Epub 2009 May 18.

 

Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.

Panoulis C, Lambrinoudaki I, Vourtsi A, Augoulea A, Kaparos G, Aravantinos L, Christodoulakos G, Creatsas G. Climacteric. 2009 Jun;12(3):240-7.

 

The role of the oxidative-stress in the endometriosis-related infertility.

Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G.

Gynecol Endocrinol. 2009 Feb;25(2):75-81. Review.

 

Irritability in Menopause: An Investigation of Its Relation to Menopausal, Hormonal and Physical Factors.

Spyropoulou AC, Zervas IM, Christodoulakos G, Lambrinoudaki I, Rizos D, Koundi K, Sanida E, Creatsas G, Soldatos CR.

Psychother Psychosom. 2009 Feb 18;78(2):128-130.

 

Additive effect of depressed mood and vasomotor symptoms on postmenopausal insomnia.

Zervas IM, Lambrinoudaki I, Spyropoulou AC, Koundi KL, Voussoura E, Tzavara C, Verdeli H, Aravantinos L, Creatsa M, Paparrigopoulos T.

Menopause. 2009 Jul-Aug;16(4):837-42.

 

Apolipoprotein E and Paraoxonase 1 polymorphisms are associated with lower serum thyroid hormones in postmenopausal women.

Lambrinoudaki I, Kaparos G, Rizos D, Galapi F, Alexandrou A, Sergentanis TN, Creatsa M, Christodoulakos G, Kouskouni E, Botsis D.

Clin Endocrinol (Oxf). 2008 Aug;71(2):284-90.

 

Parity is associated with lower cervical E-cadherin expression in postmenopausal women.

Sioulas V, Lambrinoudaki I, Politi E, Kyroudi A, Sergentanis TN, Panoulis C, Augoulea A, Kaparos G, Creatsa M, Koutselini H, Papadias K.

J Obstet Gynaecol Res. 2008 Dec;34(6):1043-8.

 

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.

Lambrinoudaki I, Vlachou S, Galapi F, Papadimitriou D, Papadias K.

Clin Interv Aging. 2008;3(3):445-51. Review.

 

Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women.

Lambrinoudaki I, Kaparos G, Papadimitriou D, Sergentanis TN, Creatsa M, Alexandrou A, Logothetis E, Christodoulakos G, Kouskouni E.

Eur J Endocrinol. 2008 Sep;159(3):233-41.

 

CSF and plasma cytokines at delivery and postpartum mood disturbances.

Boufidou F, Lambrinoudaki I, Argeitis J, Zervas IM, Pliatsika P, Leonardou AA, Petropoulos G, Hasiakos D, Papadias K, Nikolaou C.

J Affect Disord 2009 May;115(1-2):287-92.

 

Apoptosis in atherosclerosis: a mini-review.

Karaflou M, Lambrinoudaki I, Christodoulakos G.

Mini Rev Med Chem. 2008 Aug;8(9):912-8. Review.

 

CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women.

Lambrinoudaki IV, Kaparos GI, Vlachou SA, Stamatelopoulos KS, Georgiopoulos GA, Sergentanis TN, Panoulis CP, Christodoulakos GE, Alexandrou AP, Kouskouni EE, Creatsa MG, Papamichael CM.

Menopause. 2008 Nov-Dec;15(6):1163-8.

 

Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Creatsa MG, Economou EV, Siasou Z, Panoulis CP, Kalligerou I, Papadias C.

Climacteric. 2008 Apr;11(2):155-65.

 

Measurable serum markers of oxidative stress response in women with endometriosis.

Lambrinoudaki IV, Augoulea A, Christodoulakos GE, Economou EV, Kaparos G, Kontoravdis A, Papadias C, Creatsas G.

Fertil Steril. 2009 Jan;91(1):46-50.

 

Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.

Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.

Maturitas. 2008 Jan 20;59(1):62-71.

 

The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.

Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.

Climacteric. 2007 Oct;10(5):400-7.

 

Pathogenesis of endometriosis: the role of defective 'immunosurveillance'.

Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G.

Eur J Contracept Reprod Health Care. 2007 Sep;12(3):194-202. Review.

 

E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.

Sioulas V, Christodoulakos G, Lambrinoudaki I, Politi E, Sergentanis TN, Creatsas G.

Fertil Steril. 2008 Apr;89(4):1018-20.

 

Thoracic endometriosis syndrome.

Augoulea A, Lambrinoudaki I, Christodoulakos G.

Respiration. 2008;75(1):113-9. Review.

 

Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps.

Kontoravdis A, Augoulea A, Lambrinoudaki I, Christodoulakos G, Tzortziotis D, Grammatikakis I, Kontoravdis N, Creatsas G.

J Obstet Gynaecol Res. 2007 Jun;33(3):294-8.

 

Bisphosphonates.

Lambrinoudaki I, Christodoulakos G, Botsis D.

Ann N Y Acad Sci. 2006 Dec;1092:397-402. Review.

 

The cardiovascular effects of selective estrogen receptor modulators.

Christodoulakos GE, Lambrinoudaki IV, Botsis DC.

Ann N Y Acad Sci. 2006 Dec;1092:374-84. Review.

 

Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.

Koundi KL, Christodoulakos GE, Lambrinoudaki IV, Zervas IM, Spyropoulou A, Fexi P, Sakkas PN, Soldatos CR, Creatsas GC. Gynecol Endocrinol. 2006 Dec;22(12):660-8.

 

Polycystic ovary syndrome in adolescents: current and future treatment options.

Mastorakos G, Lambrinoudaki I, Creatsas G.

Paediatr Drugs. 2006;8(5):311-8. Review.

 

Macroprolactinemia. Is treatment necessary?

Lambrinoudaki IV, Daskalaki OD, Thomopoulos SA, Schinochoritis P, Argyropoulos AB.

Hormones (Athens). 2003 Jul-Sep;2(3):183-5.

 

Body composition in asymptomatic HIV-infected men: cross-sectional and prospective assessment.

Lazanas MC, Lambrinoudaki IV, Douskas GA, Tsekes GA, Chini MN, Georgiou EK.

Hormones (Athens). 2003 Jan-Mar;2(1):43-8.

 

Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.

Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Vitoratos N, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.

Atherosclerosis. 2007 Jul;193(1):142-50. Epub 2006 Jul 13.

 

Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.

Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D.

Eur J Endocrinol. 2006 Jun;154(6):907-16.

 

Endogenous sex steroids and circulating homocysteine in healthy Greek postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Rizos DA, Alexandrou A, Kountouris AV, Creatsas GC.

Hormones (Athens). 2006 Jan-Mar;5(1):35-41.

 

Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.

Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.

J Cardiovasc Pharmacol. 2006 Apr;47(4):542-8.

 

Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.

Lambrinoudaki I, Christodoulakos G, Aravantinos L, Antoniou A, Rizos D, Chondros C, Kountouris A, Chrysofakis G, Creatsas G.

J Bone Miner Metab. 2006;24(1):65-71.

 

The effect of low dose hormone therapy on mammographic breast density.

Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Vlachou S, Creatsa M, Panoulis KP, Botsis D.

Maturitas. 2006 Apr 20;54(1):78-85.

 

The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study.

Botsis D, Christodoulakos G, Papagianni V, Lambrinoudaki I, Aravantinos L, Makrakis E, Creatsas G.

Maturitas. 2006 Feb 20;53(3):362-8.

 

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.

Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.

Maturitas. 2006 Mar 20;53(4):413-23.

 

Cardiovascular disease: screening and management of the a-symptomatic high-risk post-menopausal woman.

Creatsas G, Christodoulakos G, Lambrinoudaki I.

Maturitas. 2005 Nov 15;52 Suppl 1:S32-7. Epub 2005 Sep 2. Review.

 

Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels.

Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G.

Gynecol Endocrinol. 2005 Apr;20(4):227-35. Review.

 

Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women.

Tentolouris N, Christodoulakos G, Lambrinoudaki I, Mandalaki E, Panoulis C, Maridaki C, Creatsas G, Katsilambros N.

J Endocrinol Invest. 2005 Apr;28(4):305-11.

 

Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.

Eleftheriades MI, Lambrinoudaki IV, Christodoulakos GE, Gregoriou OV, Economou EV, Kouskouni EE, Antoniou AG, Perrea DN, Dontas IA, Raptou PD, Lyritis GP, Creatsas GC.

Contraception. 2005 May;71(5):362-71.

 

Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.

Maturitas. 2005 Apr 11;50(4):321-30.

 

Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Papadias C, Economou E, Creatsas G.

Fertil Steril. 2004 Sep;82(3):634-8.

 

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.

Gynecol Endocrinol. 2004 May;18(5):244-57.

 

Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Papadias C, Sarandakou A, Liakakos T, Alexandrou A, Creatsas G.

Eur J Endocrinol. 2004 Aug;151(2):187-92.

 

Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.

Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.

Maturitas. 2004 Jun 15;48(2):107-13.

 

The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women.

Christodoulakos GE, Panoulis CP, Lambrinoudaki IV, Botsis DS, Dendrinos SG, Economou E, Creatsas GC.

Menopause. 2004 May-Jun;11(3):299-305.

 

Determinants of serum leptin levels in healthy postmenopausal women.

Lambrinoudaki I, Christodoulakos G, Panoulis C, Botsis D, Rizos D, Augoulea A, Creatsas G.

J Endocrinol Invest. 2003 Dec;26(12):1225-30.

 

Effect of hormone replacement therapy and tibolone on serum total homocysteine levels in postmenopausal women.

Christodoulakos GE, Panoulis CP, Lambrinoudaki IV, Dendrinos SG, Rizos DA, Creatsas GC.

Eur J Obstet Gynecol Reprod Biol. 2004 Jan 15;112(1):74-9.

 

Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy.

Creatsas G, Christodoulakos G, Lambrinoudaki I, Panoulis C, Chondros C, Patramanis P.

J Endocrinol Invest. 2003 Jun;26(6):545-51.

 

The effect of various regimens of hormone replacement therapy on mammographic breast density.

Christodoulakos GE, Lambrinoudaki IV, Panoulis KP, Vourtsi AD, Vlachos L, Georgiou E, Creatsas GC.

Maturitas. 2003 Jun 30;45(2):109-18.

 

Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Rizos D, Coutoukos J, Creatsas G.

Fertil Steril. 2003 Feb;79(2):455-6. No abstract available.

 

Breast pain and mammographic density increase as a consequence of raloxifene therapy.

Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Panoulis KP, Creatsas GC.

J Endocrinol Invest. 2002 Jun;25(6):564-6.

 

Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study.

Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Panoulis KP, Kelekis DA, Creatsas GC.

Menopause. 2002 Mar-Apr;9(2):110-6.

 

Management of steroid-induced osteoporosis.

Lambrinoudaki I, Kung AW.

Chin Med J (Engl). 2000 Aug;113(8):681-5. Review.

 

Absence of high-risk "s" allele associated with osteoporosis at the intronic SP1 binding-site of collagen Ialpha1 gene in Southern Chinese.

Lambrinoudaki I, Kung AW.

J Endocrinol Invest. 2001 Jul-Aug;24(7):499-502.

 

Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.

Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, Kung AW.

J Rheumatol. 2000 Jul;27(7):1759-65.

 

Body composition assessment by dual-energy x-ray absorptiometry: comparison of prone and supine measurements.

Lambrinoudaki I, Georgiou E, Douskas G, Tsekes G, Kyriakidis M, Proukakis C.

Metabolism. 1998 Nov;47(11):1379-82.

 

Body composition changes in chronic hemodialysis patients before and after hemodialysis as assessed by dual-energy x-ray absorptiometry.

Georgiou E, Virvidakis K, Douskas G, Lambrinoudaki I, Voudiklari S, Katsoudas S, Mountokalakis T, Proukakis C.

Metabolism. 1997 Sep;46(9):1059-62.

 

The SCH9 protein kinase mRNA contains a long 5' leader with a small open reading frame.

di Blasi F, Carra E, de Vendittis E, Masturzo P, Burderi E, Lambrinoudaki I, Mirisola MG, Seidita G, Fasano O.

Yeast. 1993 Jan;9(1):21-32.

 
 
Διαφήμιση
Διαφήμιση